Glucocorticoid/NN
receptors/NNS
,/,
fibromyalgia/NN
and/CC
low/JJ
back/JJ
pain/NN
./.

Recently/RB
,/,
fibromyalgia/NN
(/(
FMS/NN
)/)
was/VBD
shown/VBN
to/TO
be/VB
a/DT
disorder/NN
associated/VBN
with/IN
an/DT
altered/JJ
functioning/NN
of/IN
the/DT
stress/NN
response/NN
system/NN
./.
=====
FMS/NN
patients/NNS
display/VBP
a/DT
hyperreactive/JJ
pituitary/JJ
adrenocorticotropic/JJ
hormone/NN
(/(
ACTH/NN
)/)
release/NN
in/IN
response/NN
to/TO
corticotropin-releasing/JJ
hormone/NN
(/(
CRH/NN
)/)
and/CC
to/TO
insulin-induced/JJ
hypoglycemia/NN
./.
=====
We/PRP
suggested/VBD
that/IN
negative/JJ
feedback/NN
of/IN
cortisol/NN
could/MD
be/VB
deranged/VBN
./.
=====
Therefore/RB
we/PRP
investigated/VBD
the/DT
properties/NNS
and/CC
function/NN
of/IN
the/DT
glucocorticoid/NN
receptors/NNS
(/(
GR/NN
)/)
in/IN
FMS/NN
patients/NNS
and/CC
compared/VBD
the/DT
results/NNS
with/IN
those/DT
of/IN
healthy/JJ
persons/NNS
and/CC
patients/NNS
with/IN
chronic/JJ
low/JJ
back/JJ
pain/NN
(/(
LBP/NN
a/DT
localized/JJ
pain/NN
condition/NN
)/)
./.
=====
Forty/CD
primary/JJ
FMS/NN
patients/NNS
(/(
F/NN
:/:
M/NN
=/JJ
36/CD
:/:
4/CD
)/)
,/,
28/CD
LBP/NN
patients/NNS
(/(
25/CD
:/:
3/CD
)/)
and/CC
14/CD
(/(
12/CD
:/:
2/CD
)/)
healthy/JJ
,/,
sedentary/JJ
control/JJ
persons/NNS
were/VBD
recruited/VBN
for/IN
the/DT
study/NN
./.
=====
Urinary/JJ
free/JJ
cortisol/NN
excretion/NN
in/IN
FMS/NN
and/CC
LBP/NN
patients/NNS
was/VBD
lower/JJR
compared/VBN
to/TO
controls/NNS
./.
=====
Only/RB
FMS/NN
patients/NNS
displayed/VBD
lower/JJR
CBG/NN
and/CC
basal/JJ
serum/NN
cortisol/NN
concentrations/NNS
when/WRB
compared/VBN
to/TO
controls/NNS
./.
=====
However/RB
,/,
plasma/NN
free/JJ
cortisol/NN
concentrations/NNS
were/VBD
similar/JJ
in/IN
the/DT
three/CD
groups/NNS
./.
=====
There/EX
was/VBD
no/DT
difference/NN
in/IN
the/DT
number/NN
of/IN
GR/NN
per/IN
cell/NN
among/IN
the/DT
three/CD
groups/NNS
(/(
FMS/NN
:/:
6498/CD
+/-/CC
252/CD
,/,
LBP/NN
:/:
6625/CD
+/-/CC
284/CD
,/,
controls/NNS
:/:
6576/CD
+/-/CC
304/CD
)/)
,/,
but/CC
the/DT
dissociation/NN
constant/NN
(/(
Kd/NN
)/)
of/IN
the/DT
FMS/NN
(/(
14.5/CD
+/-/CC
0.9/CD
nmol/l/NN
)/)
and/CC
LBP/NN
(/(
14.7/CD
+/-/CC
1.3/CD
nmol/l/NN
)/)
subjects/NNS
was/VBD
significantly/RB
higher/JJR
than/IN
that/DT
of/IN
the/DT
controls/NNS
(/(
10.9/CD
+/-/CC
0.8/CD
nmol/l/NN
)/)
(/(
p/NN
</JJR
.05/CD
)/)
./.
=====
The/DT
maximal/JJ
stimulation/NN
of/IN
the/DT
lymphocytes/NNS
,/,
as/IN
measured/VBN
by/IN
the/DT
maximal/JJ
thymidine/NN
incorporation/NN
(/(
in/IN
the/DT
absence/NN
of/IN
cortisol/NN
)/)
in/IN
the/DT
FMS/NN
group/NN
was/VBD
approximately/RB
1.5/CD
times/NNS
higher/JJR
(/(
p/NN
</JJR
.05/CD
)/)
than/IN
in/IN
the/DT
control/JJ
or/CC
LBP/NN
group/NN
./.
=====
The/DT
ED50/NN
(/(
the/DT
cortisol/NN
concentration/NN
giving/VBG
50/CD
%/NN
inhibition/NN
of/IN
the/DT
thymidine/JJ
incorporation/NN
)/)
,/,
however/RB
,/,
was/VBD
identical/JJ
in/IN
all/DT
three/CD
groups/NNS
./.
=====
We/PRP
conclude/VBP
that/IN
FMS/NN
patients/NNS
have/VBP
a/DT
mild/JJ
hypocortisolemia/NN
,/,
increased/VBN
cortisol/NN
feedback/NN
resistance/NN
in/IN
combination/NN
probably/RB
with/IN
a/DT
reduced/VBN
CRH/NN
synthesis/NN
or/CC
release/NN
in/IN
the/DT
hypothalamus/NN
./.
=====
The/DT
role/NN
of/IN
the/DT
GR/NN
and/CC
mineralocorticoid/NN
receptor/NN
(/(
MR/NN
)/)
in/IN
the/DT
CRH/NN
regulation/NN
in/IN
the/DT
FMS/NN
patients/NNS
remains/VBZ
to/TO
be/VB
solved/VBN
./.